Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ketty Peris

Showing results (471-480 of 534) with videos related to

Pageof 54
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 22, 2022
Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline - Update 2022Marie-Léa Gauci, Cynthia Aristei, Jurgen C Becker, et al.
Dermatology and Therapy|July 1, 2022
Update on the Management of Pediatric Psoriasis: An Italian ConsensusKetty Peris, Anna Belloni Fortina, Luca Bianchi, et al.
The British Journal of Dermatology|July 21, 2022
Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer PatientsVasiliki A Nikolaou, Zoe Apalla, Cristina Carrera, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2022
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022Claus Garbe, Teresa Amaral, Ketty Peris, et al.
Dermatology and Therapy|January 6, 2026
Clinical Trial Eligibility in Atopic Dermatitis: Data from a Large Real-World International CohortJosé Miguel Alvarenga, Jensen Yeung, Vimal Prajapati, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 6, 2025
Drug survival of dupilumab, tralokinumab and upadacitinib in patients with atopic dermatitis: An international, real-world comparative studyTiago Torres, Jensen Yeung, Vimal Prajapati, et al.
JAMA Dermatology|December 23, 2024
Immune Checkpoint Inhibitor-Induced Vitiligo-Like DepigmentationMichela Starace, Stephano Cedirian, Luca Rapparini, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2022
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022Claus Garbe, Teresa Amaral, Ketty Peris, et al.
Human Molecular Genetics|July 31, 2018
Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanomaFangyi Gu, Ting-Huei Chen, Ruth M Pfeiffer, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2020
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and preventionAlexander J Stratigos, Claus Garbe, Clio Dessinioti, et al.
Pageof 54

Showing results (471-480 of 534) with videos related to

Sort By:
Pageof 54
European Journal of Cancer (Oxford, England : 1990)|June 22, 2022
Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline - Update 2022Marie-Léa Gauci, Cynthia Aristei, Jurgen C Becker, et al.
Dermatology and Therapy|July 1, 2022
Update on the Management of Pediatric Psoriasis: An Italian ConsensusKetty Peris, Anna Belloni Fortina, Luca Bianchi, et al.
The British Journal of Dermatology|July 21, 2022
Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer PatientsVasiliki A Nikolaou, Zoe Apalla, Cristina Carrera, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2022
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022Claus Garbe, Teresa Amaral, Ketty Peris, et al.
Dermatology and Therapy|January 6, 2026
Clinical Trial Eligibility in Atopic Dermatitis: Data from a Large Real-World International CohortJosé Miguel Alvarenga, Jensen Yeung, Vimal Prajapati, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 6, 2025
Drug survival of dupilumab, tralokinumab and upadacitinib in patients with atopic dermatitis: An international, real-world comparative studyTiago Torres, Jensen Yeung, Vimal Prajapati, et al.
JAMA Dermatology|December 23, 2024
Immune Checkpoint Inhibitor-Induced Vitiligo-Like DepigmentationMichela Starace, Stephano Cedirian, Luca Rapparini, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2022
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022Claus Garbe, Teresa Amaral, Ketty Peris, et al.
Human Molecular Genetics|July 31, 2018
Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanomaFangyi Gu, Ting-Huei Chen, Ruth M Pfeiffer, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2020
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and preventionAlexander J Stratigos, Claus Garbe, Clio Dessinioti, et al.
Pageof 54